AR010314A1 - Empleo de cromanos sustituidos con sulfonamida, como medicamento o agente de diagnostico - Google Patents
Empleo de cromanos sustituidos con sulfonamida, como medicamento o agente de diagnosticoInfo
- Publication number
- AR010314A1 AR010314A1 ARP970105574A ARP970105574A AR010314A1 AR 010314 A1 AR010314 A1 AR 010314A1 AR P970105574 A ARP970105574 A AR P970105574A AR P970105574 A ARP970105574 A AR P970105574A AR 010314 A1 AR010314 A1 AR 010314A1
- Authority
- AR
- Argentina
- Prior art keywords
- atoms
- treatment
- hydrogen
- arrhythmias
- substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Empleo de cromanos sustituidos con sulfonamida como medicamento o agente de diagnostico que comprende la formula (I) en la que R(A) significa hidrogeno,OH, -O(CO)-alquilo con 1, 2, 3, o 4 átomos de C u O-SO2-alquilo con 1, 2, 3 o 4 átomos de C;R(B ) significa hidrogeno; o R(A) y R(B) significan juntos unenlace; en donde R(1) y R(2) tal como figuran en la memoria descriptiva, R(3) significa R(9)-CnH2n[NR(11)]m; R(9) significa hidrogeno o cicloalquilo con 3,4, 5, 6, 7, u 8 átomos de C; n,m, R (11) y R(9), tal como figuran en la memoria descriptiva, R(4) significa R(12)-CrH2r, R(12) significa hidrogeno ,cicloalquilo con 3, 4, 5, 6, 7 u 8 átomos de C, piperidilo, 1-pirrolidino, N morfolino, N-metilpiperazino, CpF2p+1, piridilo,tienilo, imidazolilo ofenilo, que no está sustituido o está sustituido con 1 o 2 sustituyentes tal como figura en la memoria descriptiva; r tal como figura en la memoriadescriptiva; indicados en las reivindicaciones son extraordinariamente adecuad os para la preparacion de un medicamento para bloquear el canal de K+,que es abierto por adenosina-monofosfato cíclico(cAMP); además para la preparacion de un medicamento para la inhibicion de la secrecion de ácidosgástricos; parael tratami ento de ulceras del estomago y de la zona intestinal, en particular el duodeno, para el tratamiento de la esofagitis recurrente, parael tratamiento de enfermedades de diarrea, para el tratamiento y la prevencion de todos los tipos dearritmias, incl uídas arritmias ventriculares ysupraventriculares, así como para el control de arritmias recurrentes y para evitar la muerte repentina del corazon como consecuencia de fibrilacionesventriculares.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19619614A DE19619614A1 (de) | 1996-05-15 | 1996-05-15 | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE1996139462 DE19639462A1 (de) | 1996-09-26 | 1996-09-26 | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
AR010314A1 true AR010314A1 (es) | 2000-06-07 |
Family
ID=26025736
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970101998A AR007115A1 (es) | 1996-05-15 | 1997-05-13 | Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su empleo para la preparacion de medicamento o agente de diagnostico, asi como medicamento que los contiene |
ARP970105574A AR010314A1 (es) | 1996-05-15 | 1997-11-26 | Empleo de cromanos sustituidos con sulfonamida, como medicamento o agente de diagnostico |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970101998A AR007115A1 (es) | 1996-05-15 | 1997-05-13 | Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su empleo para la preparacion de medicamento o agente de diagnostico, asi como medicamento que los contiene |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0807629B1 (es) |
JP (1) | JP4234798B2 (es) |
KR (1) | KR100547921B1 (es) |
CN (1) | CN1204134C (es) |
AR (2) | AR007115A1 (es) |
AT (1) | ATE260909T1 (es) |
AU (1) | AU711986B2 (es) |
BR (1) | BR9703161A (es) |
CA (1) | CA2205477A1 (es) |
CZ (1) | CZ149497A3 (es) |
DE (1) | DE59711352D1 (es) |
DK (1) | DK0807629T3 (es) |
ES (1) | ES2218617T3 (es) |
HK (1) | HK1006640A1 (es) |
HR (1) | HRP970255B1 (es) |
HU (1) | HUP9700903A3 (es) |
IL (1) | IL120827A (es) |
NO (1) | NO315556B1 (es) |
NZ (1) | NZ314800A (es) |
PL (1) | PL191330B1 (es) |
PT (1) | PT807629E (es) |
SK (1) | SK283837B6 (es) |
TR (1) | TR199700369A2 (es) |
TW (1) | TW496866B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ329200A (en) * | 1996-12-16 | 1999-05-28 | Hoechst Ag | Sulphonamide substituted quinazoline, isoquinoline, quinoline or benzo[1,3-]oxazine derivatives and medicaments |
DE19705133A1 (de) * | 1997-02-11 | 1998-08-13 | Hoechst Ag | Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19706675A1 (de) * | 1997-02-20 | 1998-08-27 | Hoechst Ag | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
EP0895994A3 (de) | 1997-08-05 | 1999-12-15 | Hoechst Marion Roussel Deutschland GmbH | Sulfonamid-substituierte Pyranopyridine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19742509A1 (de) * | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
DE19742508A1 (de) | 1997-09-26 | 1999-04-01 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
DE19748469A1 (de) * | 1997-11-03 | 1999-05-06 | Hoechst Marion Roussel De Gmbh | Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
AU754204B2 (en) | 1998-09-01 | 2002-11-07 | Bristol-Myers Squibb Company | Potassium channel inhibitors and method |
DE19858253A1 (de) | 1998-12-17 | 2000-06-21 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden |
US7368582B2 (en) | 2003-10-17 | 2008-05-06 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them |
JP4840594B2 (ja) * | 2004-03-23 | 2011-12-21 | 日産化学工業株式会社 | 抗不整脈薬としての3環性ベンゾピラン化合物 |
US7884109B2 (en) | 2005-04-05 | 2011-02-08 | Wyeth Llc | Purine and imidazopyridine derivatives for immunosuppression |
US7989459B2 (en) | 2006-02-17 | 2011-08-02 | Pharmacopeia, Llc | Purinones and 1H-imidazopyridinones as PKC-theta inhibitors |
US7902187B2 (en) | 2006-10-04 | 2011-03-08 | Wyeth Llc | 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
CL2007002866A1 (es) | 2006-10-04 | 2008-07-04 | Pharmacopeia Inc | Compuestos derivados de 6-sustituidos-2-(bencimidazolil) purina y purinona; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades autoinmunes, enfermedad inflamatoria, enfermedad mediada por m |
US7915268B2 (en) | 2006-10-04 | 2011-03-29 | Wyeth Llc | 8-substituted 2-(benzimidazolyl)purine derivatives for immunosuppression |
EP2426133B1 (en) * | 2009-04-30 | 2015-12-16 | Nissan Chemical Industries, Ltd. | Novel crystal forms of tricyclic benzopyran compound and processes for producing same |
TWI583677B (zh) * | 2012-09-21 | 2017-05-21 | 日本臟器製藥股份有限公司 | 香豆素衍生物 |
CN103012380B (zh) * | 2013-01-10 | 2015-03-04 | 山东大学 | 一种色满类化合物及其制备方法与应用 |
JP6089055B2 (ja) * | 2014-03-20 | 2017-03-01 | 日本臓器製薬株式会社 | クマリン誘導体を含有する医薬 |
AR117169A1 (es) | 2018-11-28 | 2021-07-14 | Bayer Ag | (tio)amidas de piridazina como compuestos fungicidas |
BR112022022595A2 (pt) | 2020-05-06 | 2022-12-20 | Bayer Ag | Piridina (tio)amidas como compostos fungicidas |
EP4149929A1 (en) | 2020-05-12 | 2023-03-22 | Bayer Aktiengesellschaft | Triazine and pyrimidine (thio)amides as fungicidal compounds |
EP4153566A1 (en) | 2020-05-19 | 2023-03-29 | Bayer CropScience Aktiengesellschaft | Azabicyclic(thio)amides as fungicidal compounds |
CN115697059A (zh) | 2020-05-27 | 2023-02-03 | 拜耳公司 | 活性化合物组合 |
WO2023078915A1 (en) | 2021-11-03 | 2023-05-11 | Bayer Aktiengesellschaft | Bis(hetero)aryl thioether (thio)amides as fungicidal compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3737195A1 (de) * | 1987-11-03 | 1989-05-18 | Bayer Ag | Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
FR2639349B1 (fr) * | 1988-11-23 | 1991-02-22 | Sanofi Sa | Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant |
US5104890A (en) * | 1989-03-28 | 1992-04-14 | Fujisawa Pharmaceutical Company, Ltd. | Benzopyran derivatives and processes for preparation thereof |
-
1997
- 1997-05-13 EP EP97107775A patent/EP0807629B1/de not_active Expired - Lifetime
- 1997-05-13 AT AT97107775T patent/ATE260909T1/de not_active IP Right Cessation
- 1997-05-13 DE DE59711352T patent/DE59711352D1/de not_active Expired - Lifetime
- 1997-05-13 DK DK97107775T patent/DK0807629T3/da active
- 1997-05-13 HR HR970255A patent/HRP970255B1/xx not_active IP Right Cessation
- 1997-05-13 SK SK603-97A patent/SK283837B6/sk unknown
- 1997-05-13 TR TR97/00369A patent/TR199700369A2/xx unknown
- 1997-05-13 AR ARP970101998A patent/AR007115A1/es not_active Application Discontinuation
- 1997-05-13 ES ES97107775T patent/ES2218617T3/es not_active Expired - Lifetime
- 1997-05-13 AU AU20806/97A patent/AU711986B2/en not_active Ceased
- 1997-05-13 NZ NZ314800A patent/NZ314800A/xx unknown
- 1997-05-13 PT PT97107775T patent/PT807629E/pt unknown
- 1997-05-13 CN CNB971115400A patent/CN1204134C/zh not_active Expired - Fee Related
- 1997-05-13 TW TW086106326A patent/TW496866B/zh not_active IP Right Cessation
- 1997-05-14 CZ CZ971494A patent/CZ149497A3/cs unknown
- 1997-05-14 JP JP13798497A patent/JP4234798B2/ja not_active Expired - Fee Related
- 1997-05-14 NO NO19972211A patent/NO315556B1/no unknown
- 1997-05-14 BR BR9703161A patent/BR9703161A/pt not_active Application Discontinuation
- 1997-05-14 IL IL12082797A patent/IL120827A/en not_active IP Right Cessation
- 1997-05-15 HU HU9700903A patent/HUP9700903A3/hu unknown
- 1997-05-15 CA CA002205477A patent/CA2205477A1/en not_active Abandoned
- 1997-05-15 PL PL319995A patent/PL191330B1/pl unknown
- 1997-05-15 KR KR10-1997-0018635A patent/KR100547921B1/ko not_active IP Right Cessation
- 1997-11-26 AR ARP970105574A patent/AR010314A1/es unknown
-
1998
- 1998-06-23 HK HK98106052A patent/HK1006640A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR010314A1 (es) | Empleo de cromanos sustituidos con sulfonamida, como medicamento o agente de diagnostico | |
Martin | Concise colour medical dictionary | |
Merhoff et al. | Laparoscopic versus open appendectomy | |
CA1337604C (en) | Phospholipid complexes of extract of vitis vinifera, their preparation process and pharmaceutical and cosmetic compositions containing them | |
RO115780B1 (ro) | Combinatie sinergica | |
Özkan et al. | Propofol sedation in total knee replacement | |
KR20100029788A (ko) | 혈관 활성 물질과 에스트로겐의 조합 및 여성 성기능 장애의 치료에서 그의 용도 | |
Green et al. | Shock and neoplasia | |
Brocklehurst et al. | Early closure of myelomeningocele, with special reference to leg movement. | |
AR011153A1 (es) | Derivados de cromano sustituido con sulfonamida, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que los contiene | |
WO2020055135A2 (ko) | 하이드로젤 패치를 포함하는 상처 또는 흉터 치료용 조성물 | |
EP0259499A1 (en) | Anti-allergic agent | |
Ruffin et al. | Role of anticholinergic drugs in treatment of peptic ulcer | |
DE3369139D1 (en) | Pyrido(3',4':4,5)furo(3,2-g) coumarines or pyrido(3,4-h)psoralenes, preparation, use in cosmetology and as medicaments and compositions containing them | |
AR011115A1 (es) | Compuestos sustituidos con sulfonamida, empleos para la preparacion de un medicamento y agente curativo | |
US4333926A (en) | Steryl-β-D-glucoside pharmaceutical compositions and use | |
ES2175582T3 (es) | Cromanos sustituidos con sulfonamida, procedimiento para su preparacion, su utilizacion como medicamento, asi como preparados farmaceuticos que los contienen. | |
ES2146348T3 (es) | Cromanilsulfonil(tio)ureas sustituidas, procedimiento para su preparacion y su utilizacion en preparados farmaceuticos, asi como preparados farmaceuticos que las contienen. | |
ATE220065T1 (de) | Benzopyranderivate und ihre verwendung zur behandlung von herzkrankheiten | |
EP2525657A1 (en) | Composition for perinatal and neonatal stroke | |
Mavligit et al. | Gastroduodenal mucosal injury during hepatic arterial infusion of chemotherapeutic agents: Lack of cytoprotection by prostaglandin E1 analogue | |
AR004331A1 (es) | Diguanidinas de acidos bencenodicarboxilicos sustituidas, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico asicomo medicamento que las contiene. | |
UY26485A1 (es) | "pirroles sustituidos" | |
Blazsó et al. | Influence of polyphloretin phosphate (PPP) on rat-paw oedema induced by prostaglandin E1 (PGE1) | |
Beecher | Research and common sense in a clinical specialty-anesthesia |